Regorafenib, nivolumab, chemo combo found safe and effective for various cancers, heading to phase 3 trial

by

Researchers at Memorial Sloan Kettering Cancer Center, New York, have concluded their phase 2 trial of chemotherapy in combination with the drugs nivolumab, and regorafenib.

Leave A Comment

Your email address will not be published. Required fields are marked *